{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-002010","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.132061+00:00","generated_at":"2026-06-07T00:30:53.250462+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bone Biologics appoints Robert Gagnon to board of directors, replacing Erick Lucera","bullets":["Robert Gagnon appointed to board effective Jan 8, 2024; Erick Lucera resigned same date.","Gagnon will chair audit committee and serve on compensation and nominating committees.","He brings 20+ years finance experience; currently CFO of Remix Therapeutics.","Board size remains at four members after appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-002010","json":"https://secwatch.observer/filing/0001493152-24-002010.json","markdown":"https://secwatch.observer/filing/0001493152-24-002010.md","text":"https://secwatch.observer/filing/0001493152-24-002010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:30:53.250462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b1376fd9b","claim":"Robert E. Gagnon was appointed as Director at Bone Biologics Corp.","evidence_excerpt":"On January 8, 2024, the Board of Directors of Bone Biologics Corporation (the “Company”) appointed Robert E. Gagnon to the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bf26e2cbd4","claim":"Erick Lucera resigned as Director at Bone Biologics Corp.","evidence_excerpt":"As previously disclosed, Erick Lucera resigned from the Board of Directors on December 27, 2023, effective as of the date Mr. Gagnon was appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224002010/0001493152-24-002010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}